0000905718-18-000786.txt : 20180910 0000905718-18-000786.hdr.sgml : 20180910 20180910154903 ACCESSION NUMBER: 0000905718-18-000786 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180910 DATE AS OF CHANGE: 20180910 EFFECTIVENESS DATE: 20180910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-320975 FILM NUMBER: 181062701 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 D 1 primary_doc.xml X0708 D LIVE 0001175680 CytoDyn Inc. 1111 MAIN STREET, SUITE 660 VANCOUVER WA WASHINGTON 98660 360-980-8524 DELAWARE RexRay Corporation CYTODYN INC REXRAY CORP Corporation true Nader Z. Pourhassan 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Director Michael D. Mulholland 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Jordan G. Naydenov 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Anthony D. Caracciolo 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Gregory A. Gould 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Michael A. Klump 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Carl C. Dockery 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Scott A. Kelly 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Biotechnology Decline to Disclose 06b false 2018-08-28 false true true true false 0 Paulson Investment Company, LLC 5670 None None 2141 W. NORTH AVE. 2ND FLOOR CHICAGO IL ILLINOIS 60647 All States false 25000000 13199385 11800615 false 119 3000000 true 0 Assumes maximum commissions earned. Excludes value of warrants to purchase up to 5,000,000 shares of common stock. 0 true Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. false CytoDyn Inc. /s/ Michael D. Mulholland Michael D. Mulholland Chief Financial Officer 2018-09-10